Analysis
Asia's startup funding climbed to its highest level in several years during the second quarter of 2026, led by a resurgence in Chinese venture activity and a broad concentration of capital into AI-focused deals, according to Crunchbase News data published July 16.
The recovery arrives after roughly two years in which Western coverage of China's venture ecosystem focused overwhelmingly on capital controls, US outbound-investment restrictions, and delisting risk for Chinese companies on American exchanges, rather than any meaningful funding rebound -- a narrative gap the new data directly challenges.
The pattern mirrors what's playing out in US venture data almost exactly: AI captured 86% of all US funding in H1 2026 and the top five managers absorbed 73.1% of total capital, and Asia's Q2 numbers show the same concentration logic, with a handful of AI-labeled deals -- including large rounds for labs like Zhipu and DeepSeek, both separately in the market for new capital or a public listing -- doing outsized work in the regional total.
A multiyear peak is a meaningfully stronger signal than a single strong quarter, since it implies the recovery has now outpaced not just recent quarters but the entire post-2022 correction in Asian venture activity that followed the initial wave of Chinese tech-regulatory crackdowns.
For global LPs, the data reopens an allocation conversation many Western funds had quietly shelved -- China-focused and pan-Asia AI funds now have a genuine funding-recovery data point to point to, even as the underlying geopolitical friction around outbound investment restrictions and export controls hasn't materially eased.
The bear case: a funding total skewed by a small number of very large AI deals can overstate the health of the broader regional ecosystem the same way US data has been criticized for doing, and structural headwinds -- US outbound-investment screening, continued chip export controls -- remain fully in place regardless of the quarter's dollar total.
What to watch next: whether Q3 data confirms the trend or reflects one unusually strong quarter, and whether US LPs with existing Asia mandates actually increase allocations in response or remain constrained by outbound-investment rules.
